Caribou is pursuing near - term opportunities to develop the platform to engineer
improved models of disease and for improved biomaterial production.
Not exact matches
«This research has broad impact, because by deepening our understanding
of cell reprogramming we have the potential to
improve disease modeling and the generation
of better sources
of patient - specific specialized cells suitable for replacement therapy,» said Plath.
Recently research published in Cancer Discovery showed that changing the schedules
of drug administration can
improve outcomes leading to more complete responses in mouse
models of the
disease.
By studying how these genes cause defects in fly and mouse
models, we can
improve our insights into the mechanisms related to human
disease,» said corresponding author and Dr. Hugo J. Bellen, professor
of neuroscience and molecular and human genetics at Baylor College
of Medicine and an investigator at the Howard Hughes Medical Institute.
They hope that these achievements might also serve as a
model for
improving the management
of other
disease stages and settings.
Now, in an article published in
Disease Models & Mechanisms, a team from the University
of Alabama at Birmingham and Stanford University School
of Medicine describe the use
of a BDNF loop domain mimetic to
improve motor function and object location memory in a mouse
model of Rett syndrome.
Combining chemotherapy and birinapant significantly
improved disease - free survival in laboratory
models of human ovarian cancer compared to using either therapy alone.
Several laboratories, including one led by Stewart Anderson
of the University
of Pennsylvania Perelman School
of Medicine, have demonstrated that transplanting inhibitory neurons from healthy mice has
improved symptoms in mice with
models of those
diseases.
«If the mouse
models are indicative
of human
disease, the combination therapy can increase the proportion
of patients who respond to therapy without additional adverse side effects and can
improve the quality
of life for cancer patients.»
Using two complementary approaches to reduce the deposits
of amyloid - beta in the brain rather than either approach alone
improved spatial navigation and memory in a mouse
model of Alzheimer's
disease.
Drugs capable
of activating silenced genes
improve survival and growth outcomes in a mouse
model of Prader - Willi syndrome (PWS), a rare and incurable childhood
disease, according to a study funded by the National Institutes
of Health (NIH).
«We think that by restoring the natural «microbial identity»
of laboratory mice, we will
improve the
modeling of complex
diseases of free - living mammals, which includes humans and their
diseases,» said Barbara Rehermann, M.D., senior author
of the paper.
Aerosol delivery
of curcumin reduced abeta deposition and
improved cognitive performance in a transgenic mouse
model of Alzheimer's
disease.
Thus there is an urgent need for systematically studying,
improving and assessing the suitability
of different animal
models for different
diseases.
FOA encourages research grant applications from institutions / organizations that propose to develop, characterize or
improve animal
models for human
disease or to
improve diagnosis and control
of diseases that might interfere with animal use for biomedical research purposes.
Early Intervention with an Estrogen Receptor β - Selective Phytoestrogenic Formulation Prolongs Survival,
Improves Spatial Recognition Memory, and Slows Progression
of Amyloid Pathology in a Female Mouse
Model of Alzheimer's
Disease.
Injecting breast cancer with oxygen - filled microbubbles makes tumors three - times more sensitive to radiation therapy and
improves survival in animal
models of the
disease.
WashU biomedical scientist G.S.M Sundaram, PhD., holds a
model of the molecule fluselenamyl, which may
improve PET scans for patients with Alzheimer's
disease.
This work provided greater mechanistic understanding
of airway remodeling that occurs as a result
of viral exacerbation in respiratory
diseases and an
improved model for predicting the response to therapeutic candidates.
This earlier period
of disease identification presents a valuable
model for early intervention and
improved assessment
of potential therapeutic approaches for ALS.
The first accurate mouse
model of an aggressive childhood muscle cancer has
improved researchers» understanding
of the cause
of the
disease and could accelerate the identification
of new...
Clinicians and investigators in the fields
of veterinary and human endocrine oncology, clinical trials, pathology, and drug development will be joined in this consortium, in order to
improve knowledge, development
of, and access to naturally occurring canine endocrine tumours, as a
model for human
disease.
My research goal is to
improve a mouse
model of this
disease by introducing pro-inflammatory cues, and to experiment with a method
of decreasing inflammation in the eye to test the idea that localized control
of inflammation could help protect vision.
The new study shows that a protein infused into the bloodstream, can
improve the healing properties
of stem cell therapy in animal
models of the
disease.
LONDON (July 16, 2017)-- Researchers have found cell receptors abnormally overexpressed in post-mortem brains
of those with Parkinson's and Alzheimer's
diseases, and that they can be inhibited in animal
models to clear toxic protein buildup, reduce brain inflammation, and
improve cognitive performance.
A new study shows that increasing the activity a critical piece
of machinery called «mTORC1» in a mouse
model of Huntington's
disease leads to
improved motor problems and brain abnormalities associated with the
disease.
These experiments are innovative because they seek to
improve a mouse
model based on current knowledge from human
disease, while also testing novel therapies that could be
of benefit for affected individuals.
Determining the mechanism for these sex - based differences in airway inflammation and the contribution
of the microbiome in animal
models would
improve our ability to treat or prevent asthma and other autoimmune
diseases in women.
In a study published in Neuron, Palop and his collaborators uncovered the therapeutic benefits
of genetically
improving these interneurons and transplanting them into the brain
of a mouse
model of Alzheimer's
disease.
Targets
of research range from basic molecular and cellular mechanisms, the manipulation
of these mechanisms in animal
models, analyses
of the genes and gene products in cardiovascular
disease, and clinical research that seeks to
improve diagnosis and therapy for patients.
The lab is working to harness this mechanism to
improve the clinical outcome in animal
models of the many neurodegenerative disorders that have an inflammatory component, including ALS, Alzheimer's and Parkinson's
diseases.
Our recent study has demonstrated that peripheral amylin treatment reduces the amyloid pathology in the brain
of Alzheimer's
disease (AD) mouse
models, and
improves their learning and memory.
Abstract: Our recent study has demonstrated that peripheral amylin treatment reduces the amyloid pathology in the brain
of Alzheimer's
disease (AD) mouse
models, and
improves their learning and memory.
http://onlinelibrary.wiley.com/doi/10.1002/asia.201600259/full Subcutaneous administration
of cyclodextrin significantly
improved spatial learning and memory deficits in Alzheimer
disease mice
model doi: 10.1084 / jem.20121239.
This earlier period
of disease identification presents a valuable
model in which to explore and
improve future assessment
of potential therapeutic approaches for ALS.
These mouse
models are useful tools to
improve our understanding
of the biological significance and functional relevance
of these polymorphisms in human
disease, particularly when validated with controlled exposures and environmental challenges.
381/12: 00 Inhibition
of CTR1 by antisense oligonucleotides in mouse
model of Wilson's
disease reduces copper accumulation and
improves liver pathology.
Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous potential to provide
improved cellular
models of human
disease.
Improved animal
models of Parkinsonism are essential to advance our understanding
of disease pathophysiology and for eventual testing
of potential therapeutics.
Also noted by IER studies are an increase in the expression levels
of silent mating type information regulation 2 homolog 1 (SIRT1), an NAD + - dependent deacetylase.20 The expression
of SIRT1, also increased by prolonged ER in rodents, is linked to the up - regulation
of cellular stress resistance and
improved outcomes in animal
models of metabolic, neurodegenerative and inflammatory
diseases.106, 107These findings have been suggestively accompanied by improvements in resilience to
disease progression in rodent
models of Type 1 diabetic nephropathy 20, survival following induced ischaemic injury 21 and a reduction in oxidative stress.105
In rodents, ketogenic diets reduce reactive oxygen species in the brain34 and reduce central inflammation and reactive oxygen species in a
model of multiple sclerosis.35 Two clinical papers have found that ketogenic diet feeding
of 12 weeks to 6 months reduced signs
of liver inflammation in obese patients with nonalcoholic fatty liver
disease (in addition to
improving various other physiological and biochemical variables).36, 37 Unfortunately, basic research into non-alcoholic fatty liver
disease has been hampered by species differences between mice and humans in their hepatic reaction to ketogenic diets.38
Furthermore, in an animal
model of Huntington's
disease, prolonged survival, reduced
disease - associated weight loss and
improved motor function was observed in animals on an alternate - day fasting diet compared to animals fed ad libitum (49).
The integrated medicine approach to patient care is considered the future
model for healthcare destined to transform the traditional
disease centric
model to one where scientific principles and extensive patient evaluation are combined to create a strategy capable
of improving current health and laying a foundation for health and vitality lasting throughout the patient's life span.
For example, KBs were recently reported to act as neuroprotective agents by raising ATP levels and reducing the production
of reactive oxygen species in neurological tissues, 80 together with increased mitochondrial biogenesis, which may help to enhance the regulation
of synaptic function.80 Moreover, the increased synthesis
of polyunsaturated fatty acids stimulated by a KD may have a role in the regulation
of neuronal membrane excitability: it has been demonstrated, for example, that polyunsaturated fatty acids modulate the excitability
of neurons by blocking voltage-gated sodium channels.81 Another possibility is that by reducing glucose metabolism, ketogenic diets may activate anticonvulsant mechanisms, as has been reported in a rat
model.82 In addition, caloric restriction per se has been suggested to exert neuroprotective effects, including
improved mitochondrial function, decreased oxidative stress and apoptosis, and inhibition
of proinflammatory mediators, such as the cytokines tumour necrosis factor - α and interleukins.83 Although promising data have been collected (see below), at the present time the real clinical benefits
of ketogenic diets in most neurological
diseases remain largely speculative and uncertain, with the significant exception
of its use in the treatment
of convulsion
diseases.
Animal
models are necessary to develop
improved diagnostics and therapeutics, as well as understanding the basic pathophysiology
of common human laryngeal
diseases.
This
model is important in that it addresses a significant
disease and can
model how to identify and change human variables to better
improve other aspects
of the complex relationships that we have with domestic and companion animals.
«But we also show several avenues [for] how to
improve crop
models, including interactions between temperature and water stress, ozone stress, sub-cellular mechanisms or
disease responses
of plants.»